Rexahn Pharmaceuticals Granted US Patent for Novel Anti-cancer Isoquinolinamine Compounds Oct 12, 2011
Rexahn Pharmaceuticals Announces Publication of Study Validating Mechanism of Action of Serdaxin® Oct 3, 2011
Rexahn Pharmaceuticals Completes Patient Enrollment for Archexin Phase II Clinical Trial in Metastatic Pancreatic Cancer Sep 28, 2011
Rexahn Pharmaceuticals to Present at the Rodman & Renshaw 13th Annual Healthcare Conference Sep 8, 2011
Rexahn Pharmaceuticals Announces US Patent Issued for CNS-based Treatment of Sexual Dysfunction Sep 6, 2011
Rexahn Pharmaceuticals Completes Patient Enrollment in Serdaxin Phase IIb Clinical Trial for Major Depressive Disorder Jun 22, 2011
Rexahn Pharmaceuticals Reports Enrollment Progress on Phase IIb Clinical Trial of Serdaxin for Depression May 5, 2011
Rexahn Pharmaceuticals to Present at Needham & Company's 10th Annual Healthcare Conference Apr 4, 2011